To include your compound in the COVID-19 Resource Center, submit it here.

Diamyd, J&J deal

Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. subsidiary terminated a 2010 deal with Diamyd

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE